Scientists at USC Stem Cell have developed a new method for creating a renewable and expandable supply of immune cell precursors that could help advance cancer immunotherapy and other treatments.
Published in the journal Cell, the study focuses on granulocyte-monocyte progenitors (GMPs), a type…
Leave a Reply